6533b82dfe1ef96bd1291624

RESEARCH PRODUCT

Management of suspected COVID-19 patients in a low prevalence region

Alida BenfanteRiccardo MessinaLaura BasileFrancesco GambinoSonia PomaBattaglia SStefania MarinoNicola ScichiloneMarta Maria ZammutoRoberto FonteStefania PrincipeGiovanni Salamone

subject

MaleRespiratory Tract DiseasesDiseaseClinical Laboratory Technique0302 clinical medicineCOVID-19 TestingHealth carePrevalence030212 general & internal medicinehealth-care managementeducation.field_of_studyrespiratory symptomsOrganizational InnovationGrey zoneCritical PathwayItalyCritical PathwaysFemaleCoronavirus InfectionsHumanPulmonary and Respiratory Medicinemedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PopulationPneumonia ViralContext (language use)Settore MED/10 - Malattie Dell'Apparato RespiratorioDiagnosis Differential03 medical and health sciencesBetacoronavirusmedicineHumansIntensive care medicineeducationPandemicsAgedrespiratory symptomInfection ControlBetacoronavirubusiness.industryCoronavirus InfectionClinical Laboratory TechniquesSARS-CoV-2Hot TopicCOVID-19Patient Care ManagementCOVID-19 Drug Treatment030228 respiratory systemEpidemic outbreakbusiness

description

The spread of the SARS-CoV-2 infection among population has imposed a re-organization of healthcare services, aiming at stratifying patients and dedicating specific areas where patients with suspected COVID-related respiratory disease could receive the necessary health care assistance while waiting for the confirmation of the diagnosis of COVID-19 disease. In this scenario, the pathway defined as a “grey zone” is strongly advocated. We describe the application of rules and pathways in a regional context with low diffusion of the infection among the general population in the attempt to provide the best care to respiratory patients with suspected COVID-19. To date, this process has avoided the worst-case scenario of intra-hospital epidemic outbreak.

10.1177/1479973120961843http://europepmc.org/articles/PMC7533917